stella
beta
Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer — Stella
Recruiting
Back to NSCLC Stage II trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov